BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Z, Xu J, Cui H, Song J, Chen J, Wei J. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus. Medicine (Baltimore) 2020;99:e20302. [PMID: 32443377 DOI: 10.1097/MD.0000000000020302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Qiu X, Wu D, Lu X, Li G, Tang Y, Jia C, Xiong Z, Wang T. PROZ Associated with Sorafenib Sensitivity May Serve as a Potential Target to Enhance the Efficacy of Combined Immunotherapy for Hepatocellular Carcinoma. Genes 2022;13:1535. [DOI: 10.3390/genes13091535] [Reference Citation Analysis]
2 Ni Z, Lu J, Huang W, Khan H, Wu X, Huang D, Shi G, Niu Y, Huang H. Transcriptomic identification of HBx-associated hub genes in hepatocellular carcinoma. PeerJ 2021;9:e12697. [PMID: 35036167 DOI: 10.7717/peerj.12697] [Reference Citation Analysis]
3 Chaitanya AK, Priya GI, Malla RR. Computational approaches to identify biomarkers, enzymes, and pathways of hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 2022. [DOI: 10.1016/b978-0-323-98807-0.00018-1] [Reference Citation Analysis]
4 Che YQ, Zhang Y, Li HB, Shen D, Cui W. Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring. J Hepatocell Carcinoma 2021;8:1241-52. [PMID: 34676182 DOI: 10.2147/JHC.S325629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 S Murthy S, Narsaiah T B. BIOINFORMATICS APPROACH ON ACTION AND MECHANISM OF BROMELAIN IN HEPATOCELLULAR CARCINOMA. Asian J Pharm Clin Res 2021. [DOI: 10.22159/ajpcr.2021.v14i9.42661] [Reference Citation Analysis]
6 Jiang X, Song T, Pan X, Zhang X, Lan Y, Bai L. PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma. Int J Gen Med 2021;14:4209-18. [PMID: 34393500 DOI: 10.2147/IJGM.S311959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Malik A, Thanekar U, Amarachintha S, Mourya R, Nalluri S, Bondoc A, Shivakumar P. "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Front Oncol 2020;10:627701. [PMID: 33718121 DOI: 10.3389/fonc.2020.627701] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]